JP2021527125A5 - - Google Patents

Info

Publication number
JP2021527125A5
JP2021527125A5 JP2021518045A JP2021518045A JP2021527125A5 JP 2021527125 A5 JP2021527125 A5 JP 2021527125A5 JP 2021518045 A JP2021518045 A JP 2021518045A JP 2021518045 A JP2021518045 A JP 2021518045A JP 2021527125 A5 JP2021527125 A5 JP 2021527125A5
Authority
JP
Japan
Prior art keywords
compound according
teeth
halogen
och
double bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021518045A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021527125A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/035833 external-priority patent/WO2019236879A1/en
Publication of JP2021527125A publication Critical patent/JP2021527125A/ja
Publication of JP2021527125A5 publication Critical patent/JP2021527125A5/ja
Priority to JP2023203259A priority Critical patent/JP7576145B2/ja
Pending legal-status Critical Current

Links

JP2021518045A 2018-06-07 2019-06-06 Sarm1阻害剤 Pending JP2021527125A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023203259A JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862682033P 2018-06-07 2018-06-07
US62/682,033 2018-06-07
PCT/US2019/035833 WO2019236879A1 (en) 2018-06-07 2019-06-06 Inhibitors of sarm1

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023203259A Division JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Publications (2)

Publication Number Publication Date
JP2021527125A JP2021527125A (ja) 2021-10-11
JP2021527125A5 true JP2021527125A5 (cg-RX-API-DMAC7.html) 2022-06-22

Family

ID=68769462

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021518045A Pending JP2021527125A (ja) 2018-06-07 2019-06-06 Sarm1阻害剤
JP2023203259A Active JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023203259A Active JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Country Status (8)

Country Link
US (1) US12338238B2 (cg-RX-API-DMAC7.html)
EP (1) EP3801500B1 (cg-RX-API-DMAC7.html)
JP (2) JP2021527125A (cg-RX-API-DMAC7.html)
CN (1) CN112839647B (cg-RX-API-DMAC7.html)
CA (1) CA3102645A1 (cg-RX-API-DMAC7.html)
ES (1) ES3028093T3 (cg-RX-API-DMAC7.html)
MA (1) MA52813A (cg-RX-API-DMAC7.html)
WO (1) WO2019236879A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7478142B2 (ja) 2018-06-07 2024-05-02 ディスアーム セラピューティクス, インコーポレイテッド Sarm1阻害剤
CA3102645A1 (en) 2018-06-07 2019-12-12 Disarm Therapeutics, Inc. Inhibitors of sarm1
EP3801503A4 (en) 2018-06-07 2021-12-08 Disarm Therapeutics, Inc. INHIBITORS OF SARM1
CA3123215C (en) 2018-12-19 2024-04-02 Disarm Therapeutics, Inc. Inhibitors of sarm1 in combination with neuroprotective agents
US12624025B2 (en) 2019-06-06 2026-05-12 Disarm Therapeutics, Inc. Inhibitors of SARM1
JP7319395B2 (ja) 2019-06-14 2023-08-01 ディスアーム セラピューティクス, インコーポレイテッド Sarm1の阻害剤
WO2021050913A1 (en) 2019-09-12 2021-03-18 Disarm Therapeutics, Inc. Inhibitors of sarm1
WO2021108602A1 (en) * 2019-11-26 2021-06-03 Disarm Therapeutics, Inc. Methods and compositions for neuroprotection
CA3174321A1 (en) 2020-04-09 2021-10-14 Disarm Therapeutics, Inc. Indazole derivatives as inhibitors of sarm1
WO2021207308A1 (en) * 2020-04-09 2021-10-14 Disarm Therapeutics, Inc. Condensed pyrazole derivatives as inhibitors of sarm1
EP4158008A4 (en) * 2020-05-27 2024-10-23 Emendobio Inc. BIALELIC KNOCKOUT OF SARM1
TW202334117A (zh) 2020-08-24 2023-09-01 美商達薩瑪治療公司 Sarm1之抑制劑
US20250361234A1 (en) * 2022-06-06 2025-11-27 Nico Therapeutics, Inc. Compounds, compositions, and methods
AU2023294765A1 (en) * 2022-06-17 2024-12-12 Sundance Biosciences, Inc. Kinase modulators and methods of use thereof
JP2026503618A (ja) 2023-01-24 2026-01-29 ディスアーム セラピューティクス, インコーポレイテッド Sarm1阻害剤としての置換された1h-ピラゾール-4-カルボキサミド
CN121399112A (zh) * 2023-04-27 2026-01-23 维泰瑞隆有限公司 Sarm1调节剂、其制备和用途

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1022214A (en) 1963-01-31 1966-03-09 Sterling Drug Inc Novel 1,3-disubstituted-1,4-dihydro-4-oxo-1,7-naphthyridines and their preparation
US3429887A (en) 1965-01-26 1969-02-25 Sterling Drug Inc 1,7-naphthyridine-3-carboxylic acid derivatives and their preparation
US3506668A (en) 1965-01-26 1970-04-14 Sterling Drug Inc Method of preparing 8-hydroxy-quinolines
US3429882A (en) 1968-03-25 1969-02-25 Geigy Chem Corp 1,2,8,9-tetraazaphenalenes
US3539567A (en) 1968-04-23 1970-11-10 Geigy Chem Corp 8-carboxy-1(2h) phthalazinones
US3624108A (en) 1968-04-23 1971-11-30 Geigy Chem Corp 7-carboxyphthalides
US3761493A (en) 1968-04-23 1973-09-25 Ciba Geigy Corp 3-dibromomethylphthalic anhydride
US3629251A (en) 1968-08-12 1971-12-21 Geigy Chem Corp Derivatives of 9-aminoalkyl-1 2 8 9-tetraazaphenalenes
US3517014A (en) 1969-06-16 1970-06-23 Sterling Drug Inc Method of preparing 8-hydroxyquinoline-3-carboxylic acids
US3711473A (en) 1970-04-06 1973-01-16 Ciba Geigy Corp 3-hydrazino-1,2,8,9-tetraazaphenalenes
DE2449252A1 (de) 1973-10-16 1975-04-17 Fuji Photo Film Co Ltd Waermeentwickelbares, lichtempfindliches material
US4207112A (en) 1974-01-29 1980-06-10 Fuji Photo Film Co., Ltd. Heat developable light-sensitive materials
JPS50123331A (cg-RX-API-DMAC7.html) 1974-03-14 1975-09-27
GB9310700D0 (en) * 1993-05-24 1993-07-07 Zeneca Ltd Novel composition
JP2004509064A (ja) * 2000-04-27 2004-03-25 アボット・ラボラトリーズ 置換フェニルファルネシルトランスフェラーゼ阻害剤
CA2443918C (en) * 2001-04-11 2012-06-05 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents containing rho kinase inhibitors
ES2211344B1 (es) 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
WO2005102345A1 (en) * 2004-03-30 2005-11-03 Alcon, Inc. Use of rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance
US20060078890A1 (en) * 2004-10-08 2006-04-13 Ole Isacson Methods for identifying parkinson's disease therapeutics
EP1899322B1 (en) * 2005-06-28 2009-09-02 Sanofi-Aventis Isoquinoline derivatives as inhibitors of rho-kinase
HRP20110839T1 (hr) * 2005-07-26 2011-12-31 Sanofi Derivati cikloheksaminizokinolona kao inhibitori rho-kinaze
US7915410B2 (en) 2005-09-09 2011-03-29 Bristol-Myers Squibb Company Acyclic IKur inhibitors
GB0605766D0 (en) 2006-03-22 2006-05-03 Ucb Sa Process
WO2008001369A1 (en) * 2006-06-27 2008-01-03 Pharmos Corporation Use of cb2 receptor agonists for promoting neurogenesis
AU2007272533A1 (en) * 2006-07-13 2008-01-17 Novartis Ag Use of trifluoromethyl substituted benzamides in the treatment of neurological disorders
JP5599783B2 (ja) * 2008-05-30 2014-10-01 アムジエン・インコーポレーテツド Pi3キナーゼの阻害薬
JP2010053073A (ja) 2008-08-28 2010-03-11 Sankyo Kasei Kk ハロゲン化イソキノリン類の製造方法
AU2010210426B2 (en) * 2009-02-06 2015-06-11 Imago Pharmaceuticals, Inc. Inhibitors of Jun N-terminal kinase
DE102011009961A1 (de) * 2011-02-01 2012-08-02 Merck Patent Gmbh 7-Azaindolderivate
USRE47009E1 (en) * 2011-02-01 2018-08-28 The Children's Hospital Of Philadelphia HDAC inhibitors and therapeutic methods using the same
WO2012178022A2 (en) 2011-06-24 2012-12-27 University Of Massachusetts Therapeutic applications targeting sarm1
WO2013005157A1 (en) * 2011-07-05 2013-01-10 Lupin Limited Sulfone derivatives and their use as pkm2 modulators for the treatment of cancer
DE102012019369A1 (de) * 2012-10-02 2014-04-03 Merck Patent Gmbh 7-Azaindolderivat
DK3013804T3 (en) 2013-06-24 2017-04-10 Merck Patent Gmbh phthalazine
WO2015050471A1 (en) 2013-10-02 2015-04-09 Obschestvo S Ogranichennoy Otvetstvennost'yu "Panacela Labs" Carbazole compounds and methods of using same
WO2015102929A1 (en) 2013-12-30 2015-07-09 Novartis Ag Tricyclic sulfonamide derivatives
FR3017868A1 (fr) * 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP6581111B2 (ja) * 2014-04-28 2019-09-25 メッドシャイン ディスカバリー インコーポレイテッド Rhoキナーゼ阻害剤としてのイソキノリンスルホン誘導体
EP3188730B1 (en) * 2014-09-05 2019-05-01 Merck Sharp & Dohme Corp. Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
US10729680B2 (en) 2016-01-14 2020-08-04 Bayer Pharma Aktiengesellschaft 5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines
EP4091622A1 (en) 2016-08-16 2022-11-23 Henry Ford Health System Compositions for the treatment of chemotherapy-induced neuropathic pain
EP3515426A1 (en) 2016-09-24 2019-07-31 Washington University INHIBITORS OF SARM1 NADase ACTIVITY AND USES THEREOF
WO2018167800A1 (en) 2017-03-13 2018-09-20 Impetis Biosciences Limited Fused bicyclic compounds, compositions and applications thereof
CA3102645A1 (en) 2018-06-07 2019-12-12 Disarm Therapeutics, Inc. Inhibitors of sarm1
JP7478142B2 (ja) 2018-06-07 2024-05-02 ディスアーム セラピューティクス, インコーポレイテッド Sarm1阻害剤
EP3801503A4 (en) 2018-06-07 2021-12-08 Disarm Therapeutics, Inc. INHIBITORS OF SARM1
CN109180642A (zh) 2018-10-04 2019-01-11 南京先进生物材料与过程装备研究院有限公司 酞嗪酮类btk抑制剂及其应用
CN109485636A (zh) 2018-10-04 2019-03-19 南京先进生物材料与过程装备研究院有限公司 一种新型btk激酶抑制剂的盐酸盐及其制备方法与用途
CN109223787A (zh) 2018-10-04 2019-01-18 南京先进生物材料与过程装备研究院有限公司 一种喜树碱和新型酞嗪酮类化合物联合用药物组合物
CN109293635A (zh) 2018-10-04 2019-02-01 南京先进生物材料与过程装备研究院有限公司 一种新型btk激酶抑制剂的p晶型及其制备方法
CN109336863A (zh) 2018-10-04 2019-02-15 南京先进生物材料与过程装备研究院有限公司 一种新型酞嗪酮类btk抑制剂、制备及其应用
CN112955150A (zh) 2018-10-19 2021-06-11 达萨玛治疗公司 与nad+或nad+前体组合的sarm1抑制剂
CN109481441A (zh) 2018-10-31 2019-03-19 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和新型甲氧基酞嗪酮类btk抑制剂联合用药物组合物及其应用
CN109394766A (zh) 2018-10-31 2019-03-01 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和对苯硝基酞嗪酮类btk抑制剂联合用药物组合物及其应用
CN109276571A (zh) 2018-10-31 2019-01-29 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和新型硝基酞嗪酮btk抑制剂联合用药物组合物及其应用
CN109331018A (zh) 2018-10-31 2019-02-15 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和硝基酞嗪酮btk抑制剂联合用药物组合物及其应用
CN109172562A (zh) 2018-10-31 2019-01-11 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和甲氧基酞嗪酮类btk抑制剂联合用药物组合物及其应用
JP7506746B2 (ja) 2020-06-25 2024-06-26 富士フイルム株式会社 腸管上皮細胞の製造方法、及びその利用

Similar Documents

Publication Publication Date Title
JP2021528488A5 (cg-RX-API-DMAC7.html)
JP2024050527A5 (cg-RX-API-DMAC7.html)
JP2024520481A5 (cg-RX-API-DMAC7.html)
JP2008510691A5 (cg-RX-API-DMAC7.html)
JP2019034943A5 (cg-RX-API-DMAC7.html)
JP2021519783A5 (cg-RX-API-DMAC7.html)
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP2021527638A5 (cg-RX-API-DMAC7.html)
JP2020502103A5 (cg-RX-API-DMAC7.html)
JP2017536395A5 (cg-RX-API-DMAC7.html)
JP2022533069A5 (cg-RX-API-DMAC7.html)
JP2015508068A5 (cg-RX-API-DMAC7.html)
RU2003133448A (ru) 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс- хемокинового рецептора
JP2016512505A5 (cg-RX-API-DMAC7.html)
JP2023535815A5 (cg-RX-API-DMAC7.html)
JP2011509309A5 (cg-RX-API-DMAC7.html)
JP2022137237A5 (cg-RX-API-DMAC7.html)
JP2023525571A5 (cg-RX-API-DMAC7.html)
JP2022522694A5 (cg-RX-API-DMAC7.html)
JP2022529806A5 (cg-RX-API-DMAC7.html)
JP2010505865A5 (cg-RX-API-DMAC7.html)
JP2024521895A5 (cg-RX-API-DMAC7.html)
JP2017505785A5 (cg-RX-API-DMAC7.html)
JP2025502943A5 (cg-RX-API-DMAC7.html)
JP2018526376A5 (cg-RX-API-DMAC7.html)